IperionX Asks for Trading Halt As Firm Seeks to Respond to Short Seller Report

MT Newswires Live11-13

IperionX (ASX:IPX) requested that its securities be placed under a trading halt pending the release of a response regarding a report released by hedge fund Spruce Point Capital Management on Wednesday, according to a Thursday Australian bourse filing.

It requested that the trading halt remain in place until either the release of the response or the start of trading on Nov. 17.

Spruce Point said that it conducted a forensic review of IperionX, concluding that it "faces significant challenges in commercial efforts that may not be fully reflected in its valuation," while also expressing concerns "with the accuracy of its financial reporting."

IperionX's Hydrogen Assisted Metallothermic Reduction (HAMR) process is not likely to reshape the industry or displace the existing Kroll process for producing titanium, per the report. It put the "downside risk" for the stock at between 70% and 95%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment